News for:

 

Click the Chemical Profile link above for detailed information. Visit Betterchem's Drug Index for… Exclusivity Patents and market exclusivity Drug Information Prescribing and other information DMFs Type 2 drug master files Databases Free access to database search 21 CFR FDA regulations for this drug Federal Register FR search results for this drug Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… RETROVIR (zidovudine) IV Infusion, GlaxoSmithKline NDA 19-951/S-019 7/25/03 8/15/03 8/15/03 RETROVIR (zidovudine) IV Infusion GlaxoSmithKline NDA 19-951/S-018 7/25/03 8/6/03 8/6/03 RETROVIR (zidovudine) IV Infusion GlaxoSmithKline NDA 19-951/S-017 2/21/02 2/21/02 RETROVIR (zidovudine) IV Infusion GlaxoSmithKline NDA 19-951/S-016 9/12/01 6/10/03 RETROVIR (zidovudine) Capsules, Syrup, & Tablets, GlaxoSmithKline NDA 19-655/S039, 19-910/S027, & 20-528/S011 10/15/03 10/17/03 10/17/03 RETROVIR (zidovudine) Capsules, Syrup, & Tablets, GlaxoSmithKline NDA 19-655/S038, 19-910/S026, & 20-518/S010 12/18/02 1/29/03 4/4/03 RETROVIR (zidovudine) Capsules, Syrup, & Tablets. GlaxoSmithKline NDA 19-655/S037, 19-910/S025, & 20-518/S009 2/21/02 2/21/02 RETROVIR (zidovudine) Capsules, Syrup, & Tablets. GlaxoSmithKline NDA 19-655/S036 10/5/01 6/16/03 RETROVIR (zidovudine) Capsules, Syrup, & Tablets. GlaxoSmithKline NDA 19-655/S032, 19-910/S021, 20-518/S004 3/30/01 4/26/01 4/26/01 RETROVIR (zidovudine) Capsules, Syrup, & Tablets. GlaxoSmithKline NDA 20-518/S8 Combivir (lamivudine/zidovudine) tablets, GlaxoSmithKline | Lamivudine/Zidovudine Tablets co-packaged w/Nevirapine Tablets, Pharmacare Limited, Tentative Approval | Lamivudine and Zidovudine Tablets, Aurobindo Pharma, Approval | Zidovudine Tablets, Roxane Labs, Tentative Approval | Zidovudine Tablets, Aurobindo Pharma, Tentative Approval | Zidovudine Oral Solution, Aurobindo Pharma, Tentative Approval | Zidovudine Syrup, Aurobindo Pharma Limited, Inc., Approval | Zidovudine Tablets, Aurobindo Pharma Limited, Inc., Approval | Zidovudine Tablets, Roxane Laboratories Inc., Approval | Zidovudine Tablets, Ranbaxy, Inc., Approval | Lamivudine 150mg/Zidovudine 300mg Fixed- Dose Tablets co-packaged w/Efavirenz 600mg Tablets, Aurbindo Pharma, Tentative Approval | Zidovudine Capsules, Aurobindo Pharma, Approval | RETROVIR (zidovudine) Capsules, GlaxoSmithKline, Labeling Revision | RETROVIR Syrup (zidovudine), GlaxoSmithKline, Labeling Revision | RETROVIR Tablets (zidovudine), GlaxoSmithKline, Labeling Revision | Combivir (lamivudine/zidovudine) Tablets, GlaxoSmithKline, Labeling Revision | RETROVIR (zidovudine) IV Solution, GlaxoSmithKline, Labeling Revision | Lamivudine 150mg/Zidovudine 300mg Tablets Co-Packaged with Abacavir Sulfate 300mg Tablets, Aurobindo Pharma, Approval | Trizivir (abacavir sulfate/lamivudine/zidovudine) tablets, GlaxoSmithKline, Labeling Revision | Lamivudine and Zidovudine Tablets, Aurobindo Pharma, Tentative Approval | Lamivudine/Zidovudine Tablets, Cipla Ltd., Tentative Approval | COMBIVIR (lamivudine/ zidovudine) tablets, GlaxoSmithKline, Labeling Revision | RETROVIR (zidovudine) IV Infusion, GlaxoSmithKline, Labeling Revision | RETROVIR (zidovudine) Capsules, GlaxoSmithKline, Labeling Revision | RETROVIR (zidovudine) Syrup, GlaxoSmithKline, Labeling Revision | Lamivudine/Zidovudine Tablets co-packaged w/Nevirapine Tablets, Pharmacare Ltd., Tentative Approval | Lamivudine/Zidovudine/Nevirapine Tablets, Aurobindo Pharma, Approval | Lamivudine/Zidovudine/Nevirapine Tablets, Cipla Ltd., Tentative Approval Visit Betterchem's Drug Index for FDA's latest approval information.   Find other drugs… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | USActives.com | Pharma Job Search | Pharma Company News © 2011 FindingHealthOnline™